Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06137144
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-11-02
Brief Title:
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants With RelapsedRefractory Haematologic Malignancies
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-02
First Submit QC Date:
November 13 2023
Study First Post Date:
2023-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-16
Last Update Post Date:
2024-05-16
Last Update Post Date Type:
ACTUAL